$30,000 of DAVITA INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the application of the Medicare Secondary Payer Act to dialysis services."
You can find more data on corporate lobbying on Quiver Quantitative.
DVA Insider Trading Activity
DVA insiders have traded $DVA stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:
- HATHAWAY INC BERKSHIRE has made 0 purchases and 2 sales selling 1,403,356 shares for an estimated $219,377,971.
- JAVIER RODRIGUEZ (Chief Executive Officer) has made 0 purchases and 2 sales selling 69,407 shares for an estimated $14,532,108.
- DAVID PAUL MAUGHAN (Chief Operating Officer, DKC) has made 0 purchases and 2 sales selling 20,529 shares for an estimated $4,089,742.
- KATHLEEN ALYCE WATERS (Chief Legal & Pub. Affairs Off) has made 0 purchases and 2 sales selling 15,405 shares for an estimated $3,210,376.
- JAMES O HEARTY (Chief Compliance Officer) sold 15,000 shares for an estimated $2,909,745
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
DVA Hedge Fund Activity
We have seen 286 institutional investors add shares of DVA stock to their portfolio, and 281 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC removed 1,220,376 shares (-4.1%) from their portfolio in Q2 2026, for an estimated $271,509,252
- BANK OF AMERICA CORP /DE/ added 410,940 shares (+170.5%) to their portfolio in Q2 2026, for an estimated $91,425,931
- NEUBERGER BERMAN GROUP LLC added 393,492 shares (+74.0%) to their portfolio in Q2 2026, for an estimated $87,544,100
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 365,569 shares (+inf%) to their portfolio in Q2 2026, for an estimated $81,331,791
- WOODLINE PARTNERS LP removed 350,172 shares (-77.3%) from their portfolio in Q2 2026, for an estimated $77,906,266
- UBS GROUP AG removed 345,349 shares (-53.1%) from their portfolio in Q2 2026, for an estimated $76,833,245
- FREESTONE GROVE PARTNERS LP removed 315,157 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $70,116,129
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DVA Analyst Ratings
Wall Street analysts have issued reports on $DVA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Deutsche Bank issued a "Buy" rating on 05/06/2026
To track analyst ratings and price targets for DVA, check out Quiver Quantitative's $DVA forecast page.
DVA Price Targets
Multiple analysts have issued price targets for $DVA recently. We have seen 5 analysts offer price targets for $DVA in the last 6 months, with a median target of $218.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $218.0 on 07/09/2026
- Ryan Langston from TD Cowen set a target price of $201.0 on 05/11/2026
- David Macdonald from Truist Securities set a target price of $205.0 on 05/08/2026
- A.J. Rice from UBS set a target price of $235.0 on 05/07/2026
- Pito Chickering from Deutsche Bank set a target price of $220.0 on 05/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
